Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 19,166 shares at $34.57 ($663K) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Open-market sale of $663k CRNX by Chief Med and Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.57 | 9,583 | $331K | 50.0% |
| 2 | $34.57 | 9,583 | $331K | 50.0% |
| Total | $34.57 avg | 19,166 | $663K | 100% |
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |